Ro31-8220 is used as a potent protein kinase C (PKC) inhibitor in biochemical and pharmacological research; it also inhibits MAPKAP-K1b, MSK1, S6K1, and GSK3β; it suppresses voltage-dependent Na⁺ channels; it exhibits neuroprotective effects against paraoxon-induced neuronal cell death in cerebellar granule neurons; it blocks paraoxon-induced caspase-3 activation; it reduces paraoxon-induced increases in phospho-PKC pan levels; and it has been shown to rescue cardiac function in MLP−/− mice in vivo.